Modernizing Medicine named 'fastest-growing company', Boston Scientific stock rated 'buy' & more –4 GI/endoscopy company key notes

Here are four recent news updates on gastroenterology and endoscopy companies.

Analyst Ratings reported that Boston Scientific has received a consensus rating of "buy" from 24 research firms.

Check-Cap, a capsule endoscopy developer, named William Densel as CEO and director.

Three analyst firms have given EndoChoice stock a $23.33 price target in the short term, according to an OTC Outlook report.

Inc. 500 released its 2015 list, which names the fastest-growing private companies in the country. Modernizing Medicine, the developer of the Electronic Medical Assistant, was named to the list. EMA Gastro is among the company's offerings.

If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at

More articles on gastroenterology:
EndoChoice ships 27 Fuse systems in Q2, FDA approves ORBERA device for obesity treatment & more – 4 GI/endoscopy company key notes
8 payment updates for gastroenterologists to know
NJ Digestive Health Center wins innovation award

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months